Cigarette smoke has a negative impact on M. tuberculosis immune response
Maria Altet Gomez (Premia de Dalt, Spain), Maria Altet Gomez, Jose Dominguez, Joan Pau Millet, Jose Maldonado, Maria Louiza de Sosa-Galvao, Angeles Jimenez, Celia Mila, Cristina Prat, Israel Molina-Pinargote, Yoel Gónzalez-Diaz, Irene Latorre
Source: International Congress 2016 – Treatment management options and costs: vitamin D, Matrix metalloproteinases (MMPs), nutrition, and human genetics
Disease area: Respiratory infections
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Maria Altet Gomez (Premia de Dalt, Spain), Maria Altet Gomez, Jose Dominguez, Joan Pau Millet, Jose Maldonado, Maria Louiza de Sosa-Galvao, Angeles Jimenez, Celia Mila, Cristina Prat, Israel Molina-Pinargote, Yoel Gónzalez-Diaz, Irene Latorre. Cigarette smoke has a negative impact on M. tuberculosis immune response. Eur Respir J 2016; 48: Suppl. 60, 2729
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
CD8-response associates with active tuberculosis and TB2-tube response in the QuantiFERON-TB-Plus kit Source: International Congress 2016 – Tuberculosis: immune responses of CD8+ T cells, value of interferon-gamma and other cytokines, Th2 responses, BCG, and biomarkers Year: 2016
The effect of smoking on QuantiFERON results in diagnosis of latent tuberculosis infection Source: International Congress 2016 – Latent tuberculosis infection Year: 2016
Interferon gamma release assays based on M. tuberculosis-specific antigens (IGRAs) in sarcoidosis patients Source: International Congress 2015 – Sarcoidosis: pathogenesis Year: 2015
Unique cytokine profiles of CD4+T cell to Acr, HBHA and MDP-1 antigens in different clinical stage of mycobacterium tuberculosis infection Source: International Congress 2014 – Future frontiers in the diagnosis of Mycobacterium tuberculosis infection Year: 2014
Additional analysis of antigen-specific Interleukin-2 release does not improve the performance of IGRAs for the differentiation of different states of mycobacterium tuberculosis infection Source: International Congress 2014 – Future frontiers in the diagnosis of Mycobacterium tuberculosis infection Year: 2014
Evaluation of the accuracy of several immune experimental diagnostic tools to distinguish active tuberculosis from latent infection Source: International Congress 2015 – Science and biomarkers in TB Year: 2015
T cell and B cell immunological responses by tuberculous antigens in Japanese populations with different bacterial antigen expressions Source: Annual Congress 2013 –Tuberculosis diagnosis Year: 2013
A combinatorial dual-immunoassay predicts reactivation risk for patients with previously incomplete treatment for latent tuberculosis infection Source: International Congress 2016 – Active and latent tuberculosis: biomarkers Year: 2016
Tuberculin skin test or interferon gamma release assay - How to detect latent tuberculosis infection in sarcoidosis patients? Source: International Congress 2015 – Sarcoidosis: clinical Year: 2015
Treatment for latent tuberculosis infection in migrants carries a low risk of hepatotoxicity Source: International Congress 2014 – Tuberculosis: from diagnosis to therapy and prevention Year: 2014
Correlation between tuberculin-skin-test and interferon-gamma-release-assays with risks factors for tuberculosis infection Source: Annual Congress 2013 –Immunological diagnosis of tuberculosis and latent tuberculosis infection Year: 2013
Tuberculin skin testing to the IGRA positive contacts of infectious tuberculosis cases for the treatment of latent tuberculosis infection Source: International Congress 2015 – Latent TB infection and screening Year: 2015
Risk of TB infection and smoking: IFN-gamma concentration increases with the cigarettes’ number in smokers Source: Annual Congress 2013 –Tuberculosis diagnosis Year: 2013
The value of immunological methods in the diagnosis of tuberculosis in patients with HIV Source: International Congress 2015 – Screening strategies in TB Year: 2015
Clinical evaluation of several biomarkers including IFN-γ for the diagnosis of tuberculosis infection Source: International Congress 2016 – Tuberculosis: immune responses of CD8+ T cells, value of interferon-gamma and other cytokines, Th2 responses, BCG, and biomarkers Year: 2016
T cells subpopulations and cytokine responses to tuberculosis antigens in blood of smoking and nonsmoking tuberculosis patients Source: Annual Congress 2013 –Diagnostic features of tuberculosis II Year: 2013
Diagnosis of latent tuberculosis infection in children with the useof different immunological methods Source: International Congress 2016 – Tuberculosis: immune responses of CD8+ T cells, value of interferon-gamma and other cytokines, Th2 responses, BCG, and biomarkers Year: 2016
Latent TB infection in health care TB workers Source: International Congress 2014 – Tuberculosis: epidemiology and public health Year: 2014
Clinical evaluation of IP-10 and MIG including IGRAs (QFT and T-SPOT) for the diagnosis of tuberculosis infection Source: International Congress 2014 – Tuberculosis: diagnosis Year: 2014
Tobacco smoke causes release of IL-16 protein from NK cells in vitro Source: International Congress 2015 – Immunomodulation: basic science and clinical aspects Year: 2015